Selected research
Industry Growth & Trends
Global Inhalation Preparation Industry Growth and Trends Forecast to 2032
Market perspective
The global Inhalation Preparation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Inhalation Preparation include GSK, Boehringer-Ingelheim, AstraZeneca, Daphne Pharmaceutical, Hengrui Medicine, Joincare Pharmaceutical, Purity Pharmaceutical, Jewim Pharmaceutical and Sphsine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Inhalation Preparation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Inhalation Preparation market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalation Preparation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalation Preparation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Inhalation Preparation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Inhalation Preparation Market by Company
GSK
Boehringer-Ingelheim
AstraZeneca
Daphne Pharmaceutical
Hengrui Medicine
Joincare Pharmaceutical
Purity Pharmaceutical
Jewim Pharmaceutical
Sphsine
Xianju Pharmaceutical
CF PharmTech
CTTQ
Inhalation Preparation Segment by Type
Nebules Inhalation Solution (NEB)
Metered Dose Inhalers (MDI)
Spary
Dry Powder Inhalation (DPI)
Inhalation Preparation Segment by Application
Pulmonary Hypertension Treatment
COPD
Inhalation Anesthesia
Asthma
Others
Inhalation Preparation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalation Preparation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Inhalation Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nebules Inhalation Solution (NEB)
- Metered Dose Inhalers (MDI)
- Spary
- Dry Powder Inhalation (DPI)
Applications
- Pulmonary Hypertension Treatment
- COPD
- Inhalation Anesthesia
- Asthma
- Others
Companies covered
- GSK
- Boehringer-Ingelheim
- AstraZeneca
- Daphne Pharmaceutical
- Hengrui Medicine
- Joincare Pharmaceutical
- Purity Pharmaceutical
- Jewim Pharmaceutical
- Sphsine
- Xianju Pharmaceutical
- CF PharmTech
- CTTQ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Inhalation Preparation Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Inhalation Preparation Sales Estimates and Forecasts (2021-2032)
- 1.3 Inhalation Preparation Market by Type
- 1.3.1 Nebules Inhalation Solution (NEB)
- 1.3.2 Metered Dose Inhalers (MDI)
- 1.3.3 Spary
- 1.3.4 Dry Powder Inhalation (DPI)
- 1.4 Global Inhalation Preparation Market Size by Type
- 1.4.1 Global Inhalation Preparation Market Size Overview by Type (2021-2032)
- 1.4.2 Global Inhalation Preparation Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Inhalation Preparation Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Inhalation Preparation Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Inhalation Preparation Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Inhalation Preparation Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Inhalation Preparation Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Inhalation Preparation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Inhalation Preparation Industry Trends
- 2.2 Inhalation Preparation Industry Drivers
- 2.3 Inhalation Preparation Industry Opportunities and Challenges
- 2.4 Inhalation Preparation Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Inhalation Preparation Revenue (2021-2026)
- 3.2 Global Top Players by Inhalation Preparation Sales (2021-2026)
- 3.3 Global Top Players by Inhalation Preparation Price (2021-2026)
- 3.4 Global Inhalation Preparation Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Inhalation Preparation Major Company Production Sites & Headquarters
- 3.6 Global Inhalation Preparation Company, Product Type & Application
- 3.7 Global Inhalation Preparation Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Inhalation Preparation Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Inhalation Preparation Players Market Share by Revenue in 2025
- 3.8.3 2025 Inhalation Preparation Tier 1, Tier 2, and Tier 3
4 Inhalation Preparation Regional Status and Outlook
- 4.1 Global Inhalation Preparation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Inhalation Preparation Historic Market Size by Region
- 4.2.1 Global Inhalation Preparation Sales in Volume by Region (2021-2026)
- 4.2.2 Global Inhalation Preparation Sales in Value by Region (2021-2026)
- 4.2.3 Global Inhalation Preparation Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Inhalation Preparation Forecasted Market Size by Region
- 4.3.1 Global Inhalation Preparation Sales in Volume by Region (2027-2032)
- 4.3.2 Global Inhalation Preparation Sales in Value by Region (2027-2032)
- 4.3.3 Global Inhalation Preparation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhalation Preparation by Application
- 5.1 Inhalation Preparation Market by Application
- 5.1.1 Pulmonary Hypertension Treatment
- 5.1.2 COPD
- 5.1.3 Inhalation Anesthesia
- 5.1.4 Asthma
- 5.1.5 Others
- 5.2 Global Inhalation Preparation Market Size by Application
- 5.2.1 Global Inhalation Preparation Market Size Overview by Application (2021-2032)
- 5.2.2 Global Inhalation Preparation Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Inhalation Preparation Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Inhalation Preparation Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Inhalation Preparation Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Inhalation Preparation Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Inhalation Preparation Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Inhalation Preparation Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 GSK Inhalation Preparation Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Boehringer-Ingelheim
- 6.2.1 Boehringer-Ingelheim Company Information
- 6.2.2 Boehringer-Ingelheim Business Overview
- 6.2.3 Boehringer-Ingelheim Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boehringer-Ingelheim Inhalation Preparation Product Portfolio
- 6.2.5 Boehringer-Ingelheim Recent Developments
- 6.3 AstraZeneca
- 6.3.1 AstraZeneca Company Information
- 6.3.2 AstraZeneca Business Overview
- 6.3.3 AstraZeneca Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 AstraZeneca Inhalation Preparation Product Portfolio
- 6.3.5 AstraZeneca Recent Developments
- 6.4 Daphne Pharmaceutical
- 6.4.1 Daphne Pharmaceutical Company Information
- 6.4.2 Daphne Pharmaceutical Business Overview
- 6.4.3 Daphne Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Daphne Pharmaceutical Inhalation Preparation Product Portfolio
- 6.4.5 Daphne Pharmaceutical Recent Developments
- 6.5 Hengrui Medicine
- 6.5.1 Hengrui Medicine Company Information
- 6.5.2 Hengrui Medicine Business Overview
- 6.5.3 Hengrui Medicine Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hengrui Medicine Inhalation Preparation Product Portfolio
- 6.5.5 Hengrui Medicine Recent Developments
- 6.6 Joincare Pharmaceutical
- 6.6.1 Joincare Pharmaceutical Company Information
- 6.6.2 Joincare Pharmaceutical Business Overview
- 6.6.3 Joincare Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Joincare Pharmaceutical Inhalation Preparation Product Portfolio
- 6.6.5 Joincare Pharmaceutical Recent Developments
- 6.7 Purity Pharmaceutical
- 6.7.1 Purity Pharmaceutical Company Information
- 6.7.2 Purity Pharmaceutical Business Overview
- 6.7.3 Purity Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Purity Pharmaceutical Inhalation Preparation Product Portfolio
- 6.7.5 Purity Pharmaceutical Recent Developments
- 6.8 Jewim Pharmaceutical
- 6.8.1 Jewim Pharmaceutical Company Information
- 6.8.2 Jewim Pharmaceutical Business Overview
- 6.8.3 Jewim Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jewim Pharmaceutical Inhalation Preparation Product Portfolio
- 6.8.5 Jewim Pharmaceutical Recent Developments
- 6.9 Sphsine
- 6.9.1 Sphsine Company Information
- 6.9.2 Sphsine Business Overview
- 6.9.3 Sphsine Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sphsine Inhalation Preparation Product Portfolio
- 6.9.5 Sphsine Recent Developments
- 6.10 Xianju Pharmaceutical
- 6.10.1 Xianju Pharmaceutical Company Information
- 6.10.2 Xianju Pharmaceutical Business Overview
- 6.10.3 Xianju Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Xianju Pharmaceutical Inhalation Preparation Product Portfolio
- 6.10.5 Xianju Pharmaceutical Recent Developments
- 6.11 CF PharmTech
- 6.11.1 CF PharmTech Company Information
- 6.11.2 CF PharmTech Business Overview
- 6.11.3 CF PharmTech Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 CF PharmTech Inhalation Preparation Product Portfolio
- 6.11.5 CF PharmTech Recent Developments
- 6.12 CTTQ
- 6.12.1 CTTQ Company Information
- 6.12.2 CTTQ Business Overview
- 6.12.3 CTTQ Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 CTTQ Inhalation Preparation Product Portfolio
- 6.12.5 CTTQ Recent Developments
7 North America by Country
- 7.1 North America Inhalation Preparation Sales by Country
- 7.1.1 North America Inhalation Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Inhalation Preparation Sales by Country (2021-2026)
- 7.1.3 North America Inhalation Preparation Sales Forecast by Country (2027-2032)
- 7.2 North America Inhalation Preparation Market Size by Country
- 7.2.1 North America Inhalation Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Inhalation Preparation Market Size by Country (2021-2026)
- 7.2.3 North America Inhalation Preparation Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Inhalation Preparation Sales by Country
- 8.1.1 Europe Inhalation Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Inhalation Preparation Sales by Country (2021-2026)
- 8.1.3 Europe Inhalation Preparation Sales Forecast by Country (2027-2032)
- 8.2 Europe Inhalation Preparation Market Size by Country
- 8.2.1 Europe Inhalation Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Inhalation Preparation Market Size by Country (2021-2026)
- 8.2.3 Europe Inhalation Preparation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Inhalation Preparation Sales by Country
- 9.1.1 Asia-Pacific Inhalation Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Inhalation Preparation Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Inhalation Preparation Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Inhalation Preparation Market Size by Country
- 9.2.1 Asia-Pacific Inhalation Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Inhalation Preparation Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Inhalation Preparation Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Inhalation Preparation Sales by Country
- 10.1.1 South America Inhalation Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Inhalation Preparation Sales by Country (2021-2026)
- 10.1.3 South America Inhalation Preparation Sales Forecast by Country (2027-2032)
- 10.2 South America Inhalation Preparation Market Size by Country
- 10.2.1 South America Inhalation Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Inhalation Preparation Market Size by Country (2021-2026)
- 10.2.3 South America Inhalation Preparation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Inhalation Preparation Sales by Country
- 11.1.1 Middle East and Africa Inhalation Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Inhalation Preparation Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Inhalation Preparation Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Inhalation Preparation Market Size by Country
- 11.2.1 Middle East and Africa Inhalation Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Inhalation Preparation Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Inhalation Preparation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Inhalation Preparation Value Chain Analysis
- 12.1.1 Inhalation Preparation Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Inhalation Preparation Production Mode & Process
- 12.2 Inhalation Preparation Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Inhalation Preparation Distributors
- 12.2.3 Inhalation Preparation Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst